Compounded vs. FDA-Approved Testosterone: What's Legal, Safe, and Worth the Risk

The Short Answer

Most testosterone prescribed in the United States is FDA-approved. But a significant and growing share comes from compounding pharmacies — and the FDA has publicly raised safety concerns about compounded testosterone since 2020. The key question for men considering TRT isn't which option is cheaper. It's whether you can actually tell the difference, and whether your clinic is transparent about what it's prescribing.

What Is Compounded Testosterone?

Compounded testosterone is a medication that is mixed, prepared, or altered by a compounding pharmacy rather than manufactured by an FDA-approved pharmaceutical company. Instead of buying a standardized product from a brand like Pfizer (Depo-Testosterone) or Endo Pharmaceuticals (Testopel), a clinic sends a prescription to a compounder who prepares the medication — often testosterone cypionate or enanthate in vials of varying concentrations — under a state pharmacy license rather than FDA drug approval.

Compounding is legal in the United States under Section 503A of the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act of 2013. It exists for legitimate purposes: providing medications when the FDA-approved version is in shortage, when a patient needs a specific dose or formulation that isn't commercially available, or when a patient has an allergy to an inactive ingredient in a commercial product.

What Is FDA-Approved Testosterone?

FDA-approved testosterone products go through the agency's New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) process. They must demonstrate bioequivalence, manufacturing quality, stability, and safety for their intended use. The FDA maintains a list of approved testosterone products including:

• Injectable testosterone cypionate (e.g., Depo-Testosterone, generic testosterone cypionate injections from Sandoz, West-Ward)
• Injectable testosterone enanthate (e.g., Delatestryl)
• Testosterone gels (e.g., AndroGel 1% and 1.62%, Testim, VoSol Gel, Fortesta)
• Transdermal patches (e.g., Androderm)
• Subcutaneous pellets (e.g., Testopel)
• Oral testosterone undecanoate (e.g., Jatenzo, Tlando, Kyzatrex)
• Intranasal testosterone (e.g., Natesto)
• Long-acting injectable testosterone undecanoate (e.g., Aveed, administered in-clinic)

Generic versions of many of these products are available and bioequivalent to their brand-name counterparts at lower cost.

Why the FDA Is Concerned About Compounded Testosterone

In January 2020, the FDA issued a Drug Safety Communication warning that compounded testosterone products had been found to have potency levels that did not match their labeled strength. The agency reported that some compounded testosterone vials tested as low as 61% of the labeled concentration, while others exceeded 120% — meaning patients were unknowingly receiving significantly less or more hormone than prescribed.

The FDA's concern is not theoretical. Inconsistent dosing can lead to:

• Sub-therapeutic levels, where the patient fails to achieve the clinical benefit they need
• Supra-therapeutic levels, which increase the risk of side effects including polycythemia (elevated red blood cell count), cardiovascular events, mood changes, and estrogen-related complications like gynecomastia
• Unpredictable blood work results, making it difficult for clinicians to adjust doses appropriately

The FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed. Unlike FDA-approved drugs, compounded products do not have to prove bioequivalence, demonstrate stability, or follow the same current Good Manufacturing Practices (cGMP) that pharmaceutical manufacturers are required to follow.

Why Clinics Still Use Compounded Testosterone

Despite the FDA's warnings, many clinics — particularly telehealth TRT providers — continue to prescribe compounded testosterone for several reasons:

1. Cost and Convenience

Compounded testosterone is often cheaper for the clinic to source than FDA-approved injectables, especially when factoring in insurance reimbursement uncertainty. Some compounding pharmacies offer bulk pricing to clinics that volume-discount their standard vials.

2. Custom Concentrations

Compounding pharmacies can prepare testosterone cypionate or enanthate in non-standard concentrations (e.g., 100 mg/mL, 200 mg/mL, or 250 mg/mL) that may not be available in FDA-approved generics. This can be useful for fine-tuning doses in patients who need unusual volumes.

3. Supply Chain Issues

Occasional shortages of FDA-approved testosterone products — which have happened periodically — push some prescribers toward compounding as a backup. The FDA's drug shortage database has listed testosterone products intermittently over the years.

4. Regulatory Gray Areas

Some compounding pharmacies operate in a regulatory gray area, claiming to be "503B outsourcing facilities" (which are subject to FDA inspection but do not have their products individually reviewed) or arguing that testosterone should not be on the FDA's "drug shortage list" that governs when compounding is permitted.

Key Differences at a Glance

Feature	FDA-Approved Testosterone	Compounded Testosterone
FDA review for safety/efficacy	✅ Yes	❌ No
Verified potency vs. label	✅ Required	⚠️ Not verified by FDA
cGMP manufacturing	✅ Required	⚠️ State pharmacy standards only
Batch-level consistency	✅ Required	⚠️ Variable
Generic options available	✅ Yes	N/A
Cost per vial	$30–$150 (generic)	$20–$80 (varies by compounder)

How to Tell Which One You're Getting

This is the most important practical question, and it's not always easy to answer. Here are steps you can take:

Ask Your Clinic Directly

A reputable TRT provider should be transparent about whether they use FDA-approved or compounded testosterone. If they cannot answer this question clearly, or if they dodge the question, treat that as a red flag. Ask specifically:

• "Do you prescribe FDA-approved testosterone, compounded testosterone, or both?"
• "Which manufacturer supplies your testosterone injectables?"
• "Is your testosterone FDA-approved or prepared by a compounding pharmacy?"

Check the Vial Label

If you receive injectable testosterone, the vial or label should identify the manufacturer. FDA-approved products will list an NDC (National Drug Code) number and the name of the pharmaceutical manufacturer (e.g., "Pfizer, Sandoz, West-Ward, Endo"). Compounded products may list a compounding pharmacy name instead.

Review Your Prescription

FDA-approved testosterone will typically be prescribed by the product name (e.g., "Testosterone Cypionate 200 mg/mL Injection, 1 mL vial"). Compounded prescriptions may be written more generically ("Testosterone Cypionate 200 mg/mL, compounded").

Ask About the Compounder

If your testosterone is compounded, ask which pharmacy prepares it and whether it is a 503A traditional compounder or a 503B outsourcing facility. 503B facilities are subject to FDA inspection and are required to follow more rigorous quality standards than 503A compounders, though their products still do not undergo individual FDA review.

When Compounding May Be Appropriate

There are legitimate scenarios where compounded testosterone makes sense:

• Drug shortages: If an FDA-approved testosterone product is on the FDA Drug Shortages List and no alternative is available, compounding may be the only option.
• Specific formulation needs: A patient who cannot tolerate an inactive ingredient in a commercial product (e.g., sesame oil in some injectables) may benefit from a compounded alternative with a different carrier.
• Non-standard dosing: Some patients require doses or concentrations not available in commercial products, though this is increasingly rare as generic options have expanded.

In these cases, the FDA's position is that compounding is permitted — provided the source is not a drug on the shortage list for which compounding is prohibited.

The Bottom Line for Men Considering TRT in 2026

The safest path is to use an FDA-approved testosterone product — preferably a generic — from a reputable manufacturer, prescribed by a licensed clinician who monitors your blood work regularly. Generic FDA-approved injectable testosterone is widely available and affordable ($30–$150 per vial depending on pharmacy and insurance), making cost a poor justification for choosing compounded alternatives in most cases.

If your clinic uses compounded testosterone, ask why, which compounder prepares it, and whether the compounder is a 503B outsourcing facility with FDA registration. The FDA's 2020 potency findings should give pause — and a clinic that cannot answer these questions directly is not a clinic you should trust with your hormone therapy.

Key Takeaways

• FDA-approved testosterone products have verified potency, quality, and safety. Compounded products do not.
• The FDA found compounded testosterone vials with potency ranging from 61% to 120%+ of labeled strength.
• Generic FDA-approved testosterone is affordable and widely available.
• Ask your clinic which manufacturer supplies their testosterone and whether it is FDA-approved.
• Compounding is legal and sometimes appropriate, but transparency matters.